nodes	percent_of_prediction	percent_of_DWPC	metapath
Orciprenaline—Isoprenaline—MAPK1—kidney cancer	0.0134	0.514	CrCbGaD
Orciprenaline—Terbutaline—BCHE—kidney cancer	0.00976	0.375	CrCbGaD
Orciprenaline—Loss of consciousness—Sorafenib—kidney cancer	0.00294	0.00302	CcSEcCtD
Orciprenaline—Cough—Sorafenib—kidney cancer	0.00292	0.003	CcSEcCtD
Orciprenaline—Diarrhoea—Temsirolimus—kidney cancer	0.00289	0.00297	CcSEcCtD
Orciprenaline—Hypertension—Sorafenib—kidney cancer	0.00289	0.00296	CcSEcCtD
Orciprenaline—Isoprenaline—CYP1A1—kidney cancer	0.00287	0.111	CrCbGaD
Orciprenaline—Musculoskeletal discomfort—Everolimus—kidney cancer	0.00286	0.00294	CcSEcCtD
Orciprenaline—Asthenia—Pazopanib—kidney cancer	0.00286	0.00293	CcSEcCtD
Orciprenaline—Myalgia—Sorafenib—kidney cancer	0.00285	0.00292	CcSEcCtD
Orciprenaline—Insomnia—Everolimus—kidney cancer	0.00284	0.00292	CcSEcCtD
Orciprenaline—Pruritus—Pazopanib—kidney cancer	0.00282	0.00289	CcSEcCtD
Orciprenaline—Cough—Sunitinib—kidney cancer	0.00281	0.00288	CcSEcCtD
Orciprenaline—Somnolence—Everolimus—kidney cancer	0.0028	0.00287	CcSEcCtD
Orciprenaline—Dizziness—Temsirolimus—kidney cancer	0.0028	0.00287	CcSEcCtD
Orciprenaline—Dry mouth—Sorafenib—kidney cancer	0.00278	0.00286	CcSEcCtD
Orciprenaline—Hypertension—Sunitinib—kidney cancer	0.00278	0.00285	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.00276	0.00284	CcSEcCtD
Orciprenaline—Insomnia—Erlotinib—kidney cancer	0.00274	0.00282	CcSEcCtD
Orciprenaline—Chest pain—Sunitinib—kidney cancer	0.00274	0.00281	CcSEcCtD
Orciprenaline—Myalgia—Sunitinib—kidney cancer	0.00274	0.00281	CcSEcCtD
Orciprenaline—Anaphylactic shock—Sorafenib—kidney cancer	0.00273	0.0028	CcSEcCtD
Orciprenaline—Diarrhoea—Pazopanib—kidney cancer	0.00272	0.0028	CcSEcCtD
Orciprenaline—Fatigue—Everolimus—kidney cancer	0.00271	0.00278	CcSEcCtD
Orciprenaline—Pain—Vinblastine—kidney cancer	0.0027	0.00277	CcSEcCtD
Orciprenaline—Pain—Everolimus—kidney cancer	0.00269	0.00276	CcSEcCtD
Orciprenaline—Vomiting—Temsirolimus—kidney cancer	0.00269	0.00276	CcSEcCtD
Orciprenaline—Shock—Sorafenib—kidney cancer	0.00269	0.00276	CcSEcCtD
Orciprenaline—Hypokalaemia—Capecitabine—kidney cancer	0.00268	0.00275	CcSEcCtD
Orciprenaline—Dry mouth—Sunitinib—kidney cancer	0.00268	0.00275	CcSEcCtD
Orciprenaline—Chills—Gemcitabine—kidney cancer	0.00266	0.00273	CcSEcCtD
Orciprenaline—Arrhythmia—Gemcitabine—kidney cancer	0.00265	0.00272	CcSEcCtD
Orciprenaline—Headache—Temsirolimus—kidney cancer	0.00265	0.00272	CcSEcCtD
Orciprenaline—Dizziness—Pazopanib—kidney cancer	0.00263	0.0027	CcSEcCtD
Orciprenaline—Oedema—Sunitinib—kidney cancer	0.00263	0.0027	CcSEcCtD
Orciprenaline—Fatigue—Erlotinib—kidney cancer	0.00262	0.00269	CcSEcCtD
Orciprenaline—Pain—Erlotinib—kidney cancer	0.00259	0.00266	CcSEcCtD
Orciprenaline—Myalgia—Dactinomycin—kidney cancer	0.00259	0.00266	CcSEcCtD
Orciprenaline—Shock—Sunitinib—kidney cancer	0.00258	0.00265	CcSEcCtD
Orciprenaline—Asthma—Capecitabine—kidney cancer	0.00255	0.00261	CcSEcCtD
Orciprenaline—Influenza—Capecitabine—kidney cancer	0.00255	0.00261	CcSEcCtD
Orciprenaline—Vomiting—Pazopanib—kidney cancer	0.00253	0.0026	CcSEcCtD
Orciprenaline—Nausea—Temsirolimus—kidney cancer	0.00251	0.00258	CcSEcCtD
Orciprenaline—Bronchospasm—Capecitabine—kidney cancer	0.0025	0.00257	CcSEcCtD
Orciprenaline—Headache—Pazopanib—kidney cancer	0.00249	0.00256	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.00249	0.00255	CcSEcCtD
Orciprenaline—Oedema—Dactinomycin—kidney cancer	0.00249	0.00255	CcSEcCtD
Orciprenaline—Body temperature increased—Everolimus—kidney cancer	0.00249	0.00255	CcSEcCtD
Orciprenaline—Sweating increased—Capecitabine—kidney cancer	0.00248	0.00255	CcSEcCtD
Orciprenaline—Abdominal discomfort—Capecitabine—kidney cancer	0.00244	0.00251	CcSEcCtD
Orciprenaline—Body temperature increased—Erlotinib—kidney cancer	0.0024	0.00246	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.00239	0.00246	CcSEcCtD
Orciprenaline—Insomnia—Sunitinib—kidney cancer	0.00238	0.00244	CcSEcCtD
Orciprenaline—Nausea—Pazopanib—kidney cancer	0.00237	0.00243	CcSEcCtD
Orciprenaline—Fatigue—Sorafenib—kidney cancer	0.00235	0.00242	CcSEcCtD
Orciprenaline—Hypertension—Vincristine—kidney cancer	0.00235	0.00241	CcSEcCtD
Orciprenaline—Pain—Sorafenib—kidney cancer	0.00233	0.0024	CcSEcCtD
Orciprenaline—Hypersensitivity—Vinblastine—kidney cancer	0.00233	0.00239	CcSEcCtD
Orciprenaline—Myalgia—Vincristine—kidney cancer	0.00232	0.00238	CcSEcCtD
Orciprenaline—Hypersensitivity—Everolimus—kidney cancer	0.00232	0.00238	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.00227	0.00233	CcSEcCtD
Orciprenaline—Asthenia—Vinblastine—kidney cancer	0.00226	0.00232	CcSEcCtD
Orciprenaline—Fatigue—Sunitinib—kidney cancer	0.00226	0.00232	CcSEcCtD
Orciprenaline—Asthenia—Everolimus—kidney cancer	0.00226	0.00232	CcSEcCtD
Orciprenaline—Cough—Gemcitabine—kidney cancer	0.00225	0.00231	CcSEcCtD
Orciprenaline—Pain—Sunitinib—kidney cancer	0.00225	0.00231	CcSEcCtD
Orciprenaline—Hypertension—Gemcitabine—kidney cancer	0.00223	0.00229	CcSEcCtD
Orciprenaline—Chills—Paclitaxel—kidney cancer	0.00223	0.00229	CcSEcCtD
Orciprenaline—Pruritus—Everolimus—kidney cancer	0.00222	0.00228	CcSEcCtD
Orciprenaline—Anaphylactic shock—Vincristine—kidney cancer	0.00222	0.00228	CcSEcCtD
Orciprenaline—Oedema—Vincristine—kidney cancer	0.00222	0.00228	CcSEcCtD
Orciprenaline—Arrhythmia—Paclitaxel—kidney cancer	0.00222	0.00228	CcSEcCtD
Orciprenaline—Chest pain—Gemcitabine—kidney cancer	0.0022	0.00226	CcSEcCtD
Orciprenaline—Myalgia—Gemcitabine—kidney cancer	0.0022	0.00226	CcSEcCtD
Orciprenaline—Asthenia—Erlotinib—kidney cancer	0.00218	0.00223	CcSEcCtD
Orciprenaline—Urticaria—Sorafenib—kidney cancer	0.00217	0.00223	CcSEcCtD
Orciprenaline—Diarrhoea—Vinblastine—kidney cancer	0.00216	0.00222	CcSEcCtD
Orciprenaline—Body temperature increased—Sorafenib—kidney cancer	0.00216	0.00222	CcSEcCtD
Orciprenaline—Diarrhoea—Everolimus—kidney cancer	0.00215	0.00221	CcSEcCtD
Orciprenaline—Hyperhidrosis—Vincristine—kidney cancer	0.00215	0.0022	CcSEcCtD
Orciprenaline—Pruritus—Erlotinib—kidney cancer	0.00215	0.0022	CcSEcCtD
Orciprenaline—Fatigue—Dactinomycin—kidney cancer	0.00214	0.0022	CcSEcCtD
Orciprenaline—Pain—Dactinomycin—kidney cancer	0.00213	0.00218	CcSEcCtD
Orciprenaline—Tension—Paclitaxel—kidney cancer	0.00212	0.00218	CcSEcCtD
Orciprenaline—Dysgeusia—Paclitaxel—kidney cancer	0.00212	0.00217	CcSEcCtD
Orciprenaline—Oedema—Gemcitabine—kidney cancer	0.00211	0.00216	CcSEcCtD
Orciprenaline—Anaphylactic shock—Gemcitabine—kidney cancer	0.00211	0.00216	CcSEcCtD
Orciprenaline—Nervousness—Paclitaxel—kidney cancer	0.0021	0.00216	CcSEcCtD
Orciprenaline—Dizziness—Vinblastine—kidney cancer	0.00209	0.00214	CcSEcCtD
Orciprenaline—Dizziness—Everolimus—kidney cancer	0.00208	0.00213	CcSEcCtD
Orciprenaline—Muscle spasms—Paclitaxel—kidney cancer	0.00208	0.00213	CcSEcCtD
Orciprenaline—Body temperature increased—Sunitinib—kidney cancer	0.00208	0.00213	CcSEcCtD
Orciprenaline—Diarrhoea—Erlotinib—kidney cancer	0.00208	0.00213	CcSEcCtD
Orciprenaline—Vision blurred—Paclitaxel—kidney cancer	0.00204	0.00209	CcSEcCtD
Orciprenaline—Hyperhidrosis—Gemcitabine—kidney cancer	0.00204	0.00209	CcSEcCtD
Orciprenaline—Tremor—Paclitaxel—kidney cancer	0.00203	0.00208	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Vincristine—kidney cancer	0.00202	0.00208	CcSEcCtD
Orciprenaline—Hypersensitivity—Sorafenib—kidney cancer	0.00201	0.00206	CcSEcCtD
Orciprenaline—Insomnia—Vincristine—kidney cancer	0.00201	0.00206	CcSEcCtD
Orciprenaline—Vomiting—Vinblastine—kidney cancer	0.00201	0.00206	CcSEcCtD
Orciprenaline—Dizziness—Erlotinib—kidney cancer	0.00201	0.00206	CcSEcCtD
Orciprenaline—Vomiting—Everolimus—kidney cancer	0.002	0.00205	CcSEcCtD
Orciprenaline—Headache—Vinblastine—kidney cancer	0.00198	0.00203	CcSEcCtD
Orciprenaline—Headache—Everolimus—kidney cancer	0.00197	0.00202	CcSEcCtD
Orciprenaline—Body temperature increased—Dactinomycin—kidney cancer	0.00197	0.00202	CcSEcCtD
Orciprenaline—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.00196	0.00201	CcSEcCtD
Orciprenaline—Asthenia—Sorafenib—kidney cancer	0.00196	0.00201	CcSEcCtD
Orciprenaline—Syncope—Paclitaxel—kidney cancer	0.00194	0.00199	CcSEcCtD
Orciprenaline—Hypersensitivity—Sunitinib—kidney cancer	0.00193	0.00199	CcSEcCtD
Orciprenaline—Pruritus—Sorafenib—kidney cancer	0.00193	0.00198	CcSEcCtD
Orciprenaline—Vomiting—Erlotinib—kidney cancer	0.00193	0.00198	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.00192	0.00197	CcSEcCtD
Orciprenaline—Fatigue—Vincristine—kidney cancer	0.00192	0.00197	CcSEcCtD
Orciprenaline—Palpitations—Paclitaxel—kidney cancer	0.00191	0.00196	CcSEcCtD
Orciprenaline—Insomnia—Gemcitabine—kidney cancer	0.00191	0.00196	CcSEcCtD
Orciprenaline—Headache—Erlotinib—kidney cancer	0.0019	0.00195	CcSEcCtD
Orciprenaline—Loss of consciousness—Paclitaxel—kidney cancer	0.0019	0.00195	CcSEcCtD
Orciprenaline—Pain—Vincristine—kidney cancer	0.0019	0.00195	CcSEcCtD
Orciprenaline—Cough—Paclitaxel—kidney cancer	0.00189	0.00194	CcSEcCtD
Orciprenaline—Asthenia—Sunitinib—kidney cancer	0.00188	0.00193	CcSEcCtD
Orciprenaline—Nausea—Vinblastine—kidney cancer	0.00187	0.00192	CcSEcCtD
Orciprenaline—Somnolence—Gemcitabine—kidney cancer	0.00187	0.00192	CcSEcCtD
Orciprenaline—Nausea—Everolimus—kidney cancer	0.00187	0.00192	CcSEcCtD
Orciprenaline—Diarrhoea—Sorafenib—kidney cancer	0.00187	0.00192	CcSEcCtD
Orciprenaline—Hypertension—Paclitaxel—kidney cancer	0.00187	0.00192	CcSEcCtD
Orciprenaline—Pruritus—Sunitinib—kidney cancer	0.00186	0.00191	CcSEcCtD
Orciprenaline—Chest pain—Paclitaxel—kidney cancer	0.00184	0.00189	CcSEcCtD
Orciprenaline—Myalgia—Paclitaxel—kidney cancer	0.00184	0.00189	CcSEcCtD
Orciprenaline—Hypersensitivity—Dactinomycin—kidney cancer	0.00183	0.00188	CcSEcCtD
Orciprenaline—Chills—Capecitabine—kidney cancer	0.00183	0.00188	CcSEcCtD
Orciprenaline—Arrhythmia—Capecitabine—kidney cancer	0.00182	0.00187	CcSEcCtD
Orciprenaline—Fatigue—Gemcitabine—kidney cancer	0.00182	0.00187	CcSEcCtD
Orciprenaline—Dizziness—Sorafenib—kidney cancer	0.0018	0.00185	CcSEcCtD
Orciprenaline—Pain—Gemcitabine—kidney cancer	0.0018	0.00185	CcSEcCtD
Orciprenaline—Nausea—Erlotinib—kidney cancer	0.0018	0.00185	CcSEcCtD
Orciprenaline—Dry mouth—Paclitaxel—kidney cancer	0.0018	0.00185	CcSEcCtD
Orciprenaline—Diarrhoea—Sunitinib—kidney cancer	0.0018	0.00184	CcSEcCtD
Orciprenaline—Asthenia—Dactinomycin—kidney cancer	0.00178	0.00183	CcSEcCtD
Orciprenaline—Oedema—Paclitaxel—kidney cancer	0.00176	0.00181	CcSEcCtD
Orciprenaline—Anaphylactic shock—Paclitaxel—kidney cancer	0.00176	0.00181	CcSEcCtD
Orciprenaline—Body temperature increased—Vincristine—kidney cancer	0.00176	0.0018	CcSEcCtD
Orciprenaline—Dysgeusia—Capecitabine—kidney cancer	0.00174	0.00178	CcSEcCtD
Orciprenaline—Dizziness—Sunitinib—kidney cancer	0.00174	0.00178	CcSEcCtD
Orciprenaline—Shock—Paclitaxel—kidney cancer	0.00174	0.00178	CcSEcCtD
Orciprenaline—Vomiting—Sorafenib—kidney cancer	0.00174	0.00178	CcSEcCtD
Orciprenaline—Hypokalaemia—Doxorubicin—kidney cancer	0.00173	0.00177	CcSEcCtD
Orciprenaline—Tachycardia—Paclitaxel—kidney cancer	0.00172	0.00177	CcSEcCtD
Orciprenaline—Headache—Sorafenib—kidney cancer	0.00171	0.00176	CcSEcCtD
Orciprenaline—Muscle spasms—Capecitabine—kidney cancer	0.00171	0.00175	CcSEcCtD
Orciprenaline—Hyperhidrosis—Paclitaxel—kidney cancer	0.00171	0.00175	CcSEcCtD
Orciprenaline—Diarrhoea—Dactinomycin—kidney cancer	0.0017	0.00175	CcSEcCtD
Orciprenaline—Vision blurred—Capecitabine—kidney cancer	0.00167	0.00172	CcSEcCtD
Orciprenaline—Vomiting—Sunitinib—kidney cancer	0.00167	0.00171	CcSEcCtD
Orciprenaline—Body temperature increased—Gemcitabine—kidney cancer	0.00167	0.00171	CcSEcCtD
Orciprenaline—Tremor—Capecitabine—kidney cancer	0.00166	0.00171	CcSEcCtD
Orciprenaline—Headache—Sunitinib—kidney cancer	0.00165	0.00169	CcSEcCtD
Orciprenaline—Influenza—Doxorubicin—kidney cancer	0.00164	0.00168	CcSEcCtD
Orciprenaline—Asthma—Doxorubicin—kidney cancer	0.00164	0.00168	CcSEcCtD
Orciprenaline—Hypersensitivity—Vincristine—kidney cancer	0.00164	0.00168	CcSEcCtD
Orciprenaline—Nausea—Sorafenib—kidney cancer	0.00162	0.00166	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.00161	0.00165	CcSEcCtD
Orciprenaline—Insomnia—Paclitaxel—kidney cancer	0.0016	0.00164	CcSEcCtD
Orciprenaline—Asthenia—Vincristine—kidney cancer	0.00159	0.00164	CcSEcCtD
Orciprenaline—Syncope—Capecitabine—kidney cancer	0.00159	0.00163	CcSEcCtD
Orciprenaline—Vomiting—Dactinomycin—kidney cancer	0.00158	0.00162	CcSEcCtD
Orciprenaline—Somnolence—Paclitaxel—kidney cancer	0.00157	0.00161	CcSEcCtD
Orciprenaline—Palpitations—Capecitabine—kidney cancer	0.00157	0.00161	CcSEcCtD
Orciprenaline—Nausea—Sunitinib—kidney cancer	0.00156	0.0016	CcSEcCtD
Orciprenaline—Loss of consciousness—Capecitabine—kidney cancer	0.00156	0.0016	CcSEcCtD
Orciprenaline—Cough—Capecitabine—kidney cancer	0.00155	0.00159	CcSEcCtD
Orciprenaline—Hypertension—Capecitabine—kidney cancer	0.00153	0.00157	CcSEcCtD
Orciprenaline—Fatigue—Paclitaxel—kidney cancer	0.00152	0.00156	CcSEcCtD
Orciprenaline—Diarrhoea—Vincristine—kidney cancer	0.00152	0.00156	CcSEcCtD
Orciprenaline—Asthenia—Gemcitabine—kidney cancer	0.00151	0.00155	CcSEcCtD
Orciprenaline—Myalgia—Capecitabine—kidney cancer	0.00151	0.00155	CcSEcCtD
Orciprenaline—Chest pain—Capecitabine—kidney cancer	0.00151	0.00155	CcSEcCtD
Orciprenaline—Pain—Paclitaxel—kidney cancer	0.00151	0.00155	CcSEcCtD
Orciprenaline—Pruritus—Gemcitabine—kidney cancer	0.00149	0.00153	CcSEcCtD
Orciprenaline—Dry mouth—Capecitabine—kidney cancer	0.00148	0.00152	CcSEcCtD
Orciprenaline—Nausea—Dactinomycin—kidney cancer	0.00148	0.00152	CcSEcCtD
Orciprenaline—Dizziness—Vincristine—kidney cancer	0.00147	0.00151	CcSEcCtD
Orciprenaline—Drowsiness—Doxorubicin—kidney cancer	0.00146	0.0015	CcSEcCtD
Orciprenaline—Oedema—Capecitabine—kidney cancer	0.00145	0.00149	CcSEcCtD
Orciprenaline—Diarrhoea—Gemcitabine—kidney cancer	0.00144	0.00148	CcSEcCtD
Orciprenaline—Shock—Capecitabine—kidney cancer	0.00142	0.00146	CcSEcCtD
Orciprenaline—Tachycardia—Capecitabine—kidney cancer	0.00141	0.00145	CcSEcCtD
Orciprenaline—Vomiting—Vincristine—kidney cancer	0.00141	0.00145	CcSEcCtD
Orciprenaline—Sweating—Doxorubicin—kidney cancer	0.0014	0.00144	CcSEcCtD
Orciprenaline—Urticaria—Paclitaxel—kidney cancer	0.0014	0.00144	CcSEcCtD
Orciprenaline—Hyperhidrosis—Capecitabine—kidney cancer	0.0014	0.00144	CcSEcCtD
Orciprenaline—Body temperature increased—Paclitaxel—kidney cancer	0.00139	0.00143	CcSEcCtD
Orciprenaline—Headache—Vincristine—kidney cancer	0.00139	0.00143	CcSEcCtD
Orciprenaline—Vomiting—Gemcitabine—kidney cancer	0.00134	0.00138	CcSEcCtD
Orciprenaline—Headache—Gemcitabine—kidney cancer	0.00132	0.00136	CcSEcCtD
Orciprenaline—Nausea—Vincristine—kidney cancer	0.00132	0.00135	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.00132	0.00135	CcSEcCtD
Orciprenaline—Insomnia—Capecitabine—kidney cancer	0.00131	0.00134	CcSEcCtD
Orciprenaline—Hypersensitivity—Paclitaxel—kidney cancer	0.0013	0.00133	CcSEcCtD
Orciprenaline—Asthenia—Paclitaxel—kidney cancer	0.00127	0.0013	CcSEcCtD
Orciprenaline—Nausea—Gemcitabine—kidney cancer	0.00125	0.00129	CcSEcCtD
Orciprenaline—Fatigue—Capecitabine—kidney cancer	0.00125	0.00128	CcSEcCtD
Orciprenaline—Pruritus—Paclitaxel—kidney cancer	0.00125	0.00128	CcSEcCtD
Orciprenaline—Pain—Capecitabine—kidney cancer	0.00124	0.00127	CcSEcCtD
Orciprenaline—Diarrhoea—Paclitaxel—kidney cancer	0.00121	0.00124	CcSEcCtD
Orciprenaline—Chills—Doxorubicin—kidney cancer	0.00118	0.00121	CcSEcCtD
Orciprenaline—Arrhythmia—Doxorubicin—kidney cancer	0.00117	0.0012	CcSEcCtD
Orciprenaline—Dizziness—Paclitaxel—kidney cancer	0.00117	0.0012	CcSEcCtD
Orciprenaline—Urticaria—Capecitabine—kidney cancer	0.00115	0.00118	CcSEcCtD
Orciprenaline—Body temperature increased—Capecitabine—kidney cancer	0.00114	0.00118	CcSEcCtD
Orciprenaline—Tension—Doxorubicin—kidney cancer	0.00112	0.00115	CcSEcCtD
Orciprenaline—Vomiting—Paclitaxel—kidney cancer	0.00112	0.00115	CcSEcCtD
Orciprenaline—Dysgeusia—Doxorubicin—kidney cancer	0.00112	0.00115	CcSEcCtD
Orciprenaline—Nervousness—Doxorubicin—kidney cancer	0.00111	0.00114	CcSEcCtD
Orciprenaline—Headache—Paclitaxel—kidney cancer	0.00111	0.00113	CcSEcCtD
Orciprenaline—Muscle spasms—Doxorubicin—kidney cancer	0.0011	0.00113	CcSEcCtD
Orciprenaline—Vision blurred—Doxorubicin—kidney cancer	0.00108	0.00111	CcSEcCtD
Orciprenaline—Hypersensitivity—Capecitabine—kidney cancer	0.00107	0.0011	CcSEcCtD
Orciprenaline—Nausea—Paclitaxel—kidney cancer	0.00105	0.00108	CcSEcCtD
Orciprenaline—Asthenia—Capecitabine—kidney cancer	0.00104	0.00107	CcSEcCtD
Orciprenaline—Syncope—Doxorubicin—kidney cancer	0.00103	0.00105	CcSEcCtD
Orciprenaline—Pruritus—Capecitabine—kidney cancer	0.00102	0.00105	CcSEcCtD
Orciprenaline—Palpitations—Doxorubicin—kidney cancer	0.00101	0.00104	CcSEcCtD
Orciprenaline—Loss of consciousness—Doxorubicin—kidney cancer	0.00101	0.00103	CcSEcCtD
Orciprenaline—Cough—Doxorubicin—kidney cancer	0.000998	0.00102	CcSEcCtD
Orciprenaline—Diarrhoea—Capecitabine—kidney cancer	0.000991	0.00102	CcSEcCtD
Orciprenaline—Hypertension—Doxorubicin—kidney cancer	0.000987	0.00101	CcSEcCtD
Orciprenaline—Myalgia—Doxorubicin—kidney cancer	0.000974	0.001	CcSEcCtD
Orciprenaline—Chest pain—Doxorubicin—kidney cancer	0.000974	0.001	CcSEcCtD
Orciprenaline—Dizziness—Capecitabine—kidney cancer	0.000957	0.000983	CcSEcCtD
Orciprenaline—Dry mouth—Doxorubicin—kidney cancer	0.000952	0.000978	CcSEcCtD
Orciprenaline—Oedema—Doxorubicin—kidney cancer	0.000933	0.000958	CcSEcCtD
Orciprenaline—Anaphylactic shock—Doxorubicin—kidney cancer	0.000933	0.000958	CcSEcCtD
Orciprenaline—Vomiting—Capecitabine—kidney cancer	0.000921	0.000945	CcSEcCtD
Orciprenaline—Shock—Doxorubicin—kidney cancer	0.000918	0.000943	CcSEcCtD
Orciprenaline—Tachycardia—Doxorubicin—kidney cancer	0.000911	0.000935	CcSEcCtD
Orciprenaline—Headache—Capecitabine—kidney cancer	0.000907	0.000931	CcSEcCtD
Orciprenaline—Hyperhidrosis—Doxorubicin—kidney cancer	0.000902	0.000926	CcSEcCtD
Orciprenaline—Nausea—Capecitabine—kidney cancer	0.00086	0.000883	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.00085	0.000873	CcSEcCtD
Orciprenaline—Insomnia—Doxorubicin—kidney cancer	0.000844	0.000867	CcSEcCtD
Orciprenaline—Somnolence—Doxorubicin—kidney cancer	0.00083	0.000852	CcSEcCtD
Orciprenaline—Fatigue—Doxorubicin—kidney cancer	0.000805	0.000826	CcSEcCtD
Orciprenaline—Pain—Doxorubicin—kidney cancer	0.000798	0.000819	CcSEcCtD
Orciprenaline—Urticaria—Doxorubicin—kidney cancer	0.000741	0.000761	CcSEcCtD
Orciprenaline—Body temperature increased—Doxorubicin—kidney cancer	0.000738	0.000757	CcSEcCtD
Orciprenaline—Hypersensitivity—Doxorubicin—kidney cancer	0.000688	0.000706	CcSEcCtD
Orciprenaline—Asthenia—Doxorubicin—kidney cancer	0.00067	0.000687	CcSEcCtD
Orciprenaline—Pruritus—Doxorubicin—kidney cancer	0.00066	0.000678	CcSEcCtD
Orciprenaline—Diarrhoea—Doxorubicin—kidney cancer	0.000639	0.000656	CcSEcCtD
Orciprenaline—Dizziness—Doxorubicin—kidney cancer	0.000617	0.000634	CcSEcCtD
Orciprenaline—Vomiting—Doxorubicin—kidney cancer	0.000593	0.000609	CcSEcCtD
Orciprenaline—Headache—Doxorubicin—kidney cancer	0.000585	0.0006	CcSEcCtD
Orciprenaline—Nausea—Doxorubicin—kidney cancer	0.000554	0.000569	CcSEcCtD
